I Peace and Vita Therapeutics to develop iPS cells for transplantation therapy

Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...

July 10, 2025 | Thursday | News
Univercells teams up with Repligen for real-time bioprocess monitoring

 Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing soluti...

July 9, 2025 | Wednesday | News
Sartorius partners with Sensible Biotechnologies to scale up cell-based mRNA design platform

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, and Sensible Biotechno...

July 9, 2025 | Wednesday | News
Korea's Celltrion announces US launch of denosumab biosimilars for osteoporosis treatment

Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...

July 8, 2025 | Tuesday | News
Japan's Shimadzu receives US FDA's premarketing notification for Positive PET system

Japan's Shimadzu Corporation has obtained premarketing notification from the US Food and Drug Administration (FDA) for i...

July 7, 2025 | Monday | News
US & Middle East explore setting up world's first-of-their kind Centres for Genome Surgery

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a l...

July 5, 2025 | Saturday | News
Thermo Fisher’s NGS assay receives US FDA approval as companion diagnostic for ZEGFROVY

Thermo Fisher Scientific, the world leader in serving science, has announced that the US Food and Drug Administration (F...

July 4, 2025 | Friday | News
Lunit and Microsoft collaborate to advance AI-driven cancer diagnosis

South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has...

July 3, 2025 | Thursday | News
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge

Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...

July 2, 2025 | Wednesday | Opinion
Vetter invests $285 M in new clinical manufacturing site in US

Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated the start o...

June 30, 2025 | Monday | News
Xcell Biosciences collaborates with Thermo Fisher to advance next generation of cell therapies

Xcell Biosciences, a San Francisco-based instrumentation company focused on cell and gene therapy applications, has anno...

June 25, 2025 | Wednesday | News
Illumina to acquire SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire Som...

June 23, 2025 | Monday | News
Shilpa Biologics targets global ADC partnerships as it prepares GMP facility launch at US BIO 2025

As the global antibody-drug conjugate (ADC) market expands — driven by both new therapeutic approvals and growing ...

June 20, 2025 | Friday | News
From Molecule to Market Treehill CEO Highlights Full Spectrum Diligence as Key to Biotech Funding

As capital markets tighten across biotech, investors are increasingly selective not only about scientific potential but ...

June 20, 2025 | Friday | Opinion
"Puerto Rico: America’s Pharma Powerhouse with Global Ambitions"

  Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke to BioSpectrum Asia and BioSpectrum Indi...

June 18, 2025 | Wednesday | News
Enzene expands NJ facility by 26,000 sq. ft., showcases strategic growth at BIO 2025

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology,  announced that ahead of the of...

June 16, 2025 | Monday | News
Abu Dhabi’s Department of Health leads global health mission to U.S. during BIO 2025

A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strateg...

June 16, 2025 | Monday | News
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025

Dr Ian Nisbet, Chief Operating Officer and co-founder of Cartherics, brings over three decades of biotech leadership exp...

June 16, 2025 | Monday | News